TLX agonist 2 (compound 31) is a TLX agonist with an EC50 of 0.1 µM and a Kd of 0.16 µM. This compound enhances transcriptional activity by binding to TLX, thereby boosting the expression of TLX target genes. TLX agonist 2 is utilized in research on neurodegenerative diseases.
Target-Kategorie:
Others|||Orphan Receptor
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
